相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients
Xingfei Pan et al.
PLOS ONE (2013)
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy
Silvia Mirandola et al.
ANTIVIRAL RESEARCH (2012)
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
Yoon-Seon Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China
Xiao-Guang Li et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Hepatitis B: Epidemiology and prevention in developing countries
Elisabetta Franco et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
James Fung et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection
Y. Liu et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B
S. Mirandola et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naive Chinese patients
Bao-Ming Liu et al.
ANTIVIRAL RESEARCH (2010)
Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients
Jing-Xian Yang et al.
ANTIVIRAL THERAPY (2010)
Coevolution and HBV drug resistance
Yury Khudyakov
ANTIVIRAL THERAPY (2010)
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes: Hepatitis B Genotypes Differ in Their Lamivudine Resistance Associated Mutation Pattern
Hans Damerow et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
Shushan Zhao et al.
VIROLOGY JOURNAL (2010)
Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir
Maria Seifer et al.
ANTIVIRAL RESEARCH (2009)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B
Haruhiko Kobashi et al.
HEPATOLOGY INTERNATIONAL (2009)
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients
Yue Han et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
Valentina Svicher et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients
Rebecca Pastor et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Chronic hepatitis B: Preventing, detecting, and managing viral resistance
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance
Carl J. Baldick et al.
HEPATOLOGY (2008)
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure
Stephen Locarnini
HEPATOLOGY INTERNATIONAL (2008)
Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C
X. P. Pan et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life
Tatsuji Maeshiro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro
Nadia Warner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
Irene Rapti et al.
HEPATOLOGY (2007)
Hepatic steatosis in hepatitis C: Comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial
Anna S. F. Lok et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
HBV drug resistance: Mechanisms, detection and interpretation
T Shaw et al.
JOURNAL OF HEPATOLOGY (2006)
Cellular and virological mechanisms of HBV drug resistance
S Locarnini et al.
JOURNAL OF HEPATOLOGY (2006)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: A prospective study
T Nakayoshi et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
NWY Leung et al.
HEPATOLOGY (2001)
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
JH Kao et al.
GASTROENTEROLOGY (2000)
分享论文
